We demonstrated that, in contrast to classical opioid receptors, ACKR3 will not result in classical G protein signaling and isn't modulated with the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. Rather, we established that LIH383, an ACKR3-selective subnanomolar https://valeriusv581xus1.answerblogs.com/profile